These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9707019

  • 1. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow.
    Hägglund H, Ringdén O, Remberger M, Lönnqvist B, Sparrelid E, Tammik L, Kumlien G.
    Bone Marrow Transplant; 1998 Jul; 22(2):131-6. PubMed ID: 9707019
    [Abstract] [Full Text] [Related]

  • 2. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Jul; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 3. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.
    Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA, Spanish Working Party for BMT in Children (GETMON).
    Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771
    [Abstract] [Full Text] [Related]

  • 4. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R, Laws HJ, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Schmitz M, Fischer J, Göbel U, Enczmann J, Dilloo D.
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [Abstract] [Full Text] [Related]

  • 5. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies.
    Vigorito AC, Azevedo WM, Marques JF, Azevedo AM, Eid KA, Aranha FJ, Lorand-Metze I, Oliveira GB, Correa ME, Reis AR, Miranda EC, de Souza CA.
    Bone Marrow Transplant; 1998 Dec; 22(12):1145-51. PubMed ID: 9894716
    [Abstract] [Full Text] [Related]

  • 6. Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors.
    Ringdén O, Hägglund H, Runde V, Basu O, Kroschinsky F, Stockschläder M, Potter MN.
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S81-4. PubMed ID: 9712503
    [Abstract] [Full Text] [Related]

  • 7. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study.
    Scott MA, Gandhi MK, Jestice HK, Mahendra P, Bass G, Marcus RE.
    Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741
    [Abstract] [Full Text] [Related]

  • 8. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE, van der Holt B, Haze S, Braakman E, Gratama JW, Löwenberg B, Cornelissen JJ.
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [Abstract] [Full Text] [Related]

  • 9. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.
    Lickliter JD, McGlave PB, DeFor TE, Miller JS, Ramsay NK, Verfaillie CM, Burns LJ, Wagner JE, Eastlund T, Dusenbery K, Weisdorf DJ.
    Bone Marrow Transplant; 2000 Oct; 26(7):723-8. PubMed ID: 11042652
    [Abstract] [Full Text] [Related]

  • 10. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC.
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [Abstract] [Full Text] [Related]

  • 11. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
    Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E.
    N Engl J Med; 2000 Jun 22; 342(25):1846-54. PubMed ID: 10861319
    [Abstract] [Full Text] [Related]

  • 12. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C.
    Bone Marrow Transplant; 1998 Dec 22; 22(12):1129-35. PubMed ID: 9894714
    [Abstract] [Full Text] [Related]

  • 13. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 14. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
    Levine JE, Wiley J, Kletzel M, Yanik G, Hutchinson RJ, Koehler M, Neudorf S.
    Bone Marrow Transplant; 2000 Jan 01; 25(1):13-8. PubMed ID: 10654008
    [Abstract] [Full Text] [Related]

  • 15. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
    Schmitz N, Beksac M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, Russell N, Apperley J, Szerm J, Bradstock K, Buzyn A, Schlegelberger B, Matcham J, Gratwohl A.
    Haematologica; 2005 May 01; 90(5):643-8. PubMed ID: 15921379
    [Abstract] [Full Text] [Related]

  • 16. Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose.
    Keever-Taylor CA, Klein JP, Eastwood D, Bredeson C, Margolis DA, Burns WH, Vesole DH.
    Bone Marrow Transplant; 2001 Apr 01; 27(8):791-800. PubMed ID: 11477435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G, Iacobelli S, Bandini G, Björkstrand B, Corradini P, Crawley C, Hegenbart U, Morgan G, Kröger N, Schattenberg A, Schönland SO, Verdonck LF, Volin L, de Witte T, Niederwieser D, Myeloma Subcommittee of the EBMT.
    Haematologica; 2007 Nov 01; 92(11):1513-8. PubMed ID: 18024400
    [Abstract] [Full Text] [Related]

  • 19. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.
    Klin Padiatr; 2004 Nov 01; 216(6):356-63. PubMed ID: 15565551
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.